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PLINICAL RESEARCH Myocardial Infarction and Stroke
oung Adult Myocardial
nfarction and Ischemic Stroke
he Role of Paradoxical Embolism
nd Thrombophilia (The YAMIS Study)
anjay Sastry, MBCHB, MRCP,* Graham Riding, FRCS,* Julie Morris, MSC,†
avid Taberner, FRCP, FRCPATH,‡ Nicola Cherry, MD, PHD, FRCP,§
nthony Heagerty, MD, FRCP, FMEDSCI, Charles McCollum, FRCS, MD*
anchester, United Kingdom; and Edmonton, Canada
OBJECTIVES We aimed to investigate the frequency of venous-to-arterial circulation shunts (v-aCS),
usually caused by patent foramen ovale (PFO), and thrombophilia in young adults suffering
myocardial infarction (MI) and ischemic stroke (IS) and matched healthy control subjects.
BACKGROUND The cause of MI and IS in young adults is often uncertain, and paradoxical embolism might
be more frequent than previously thought.
METHODS Young adults (ages 16 to 39 years) surviving MI (n  101) and IS (n  101) between 1993
and 1998 were matched by age and gender to 202 control subjects from the same general
practitioner practices. The v-aCS were detected by transcranial Doppler after intravenous
microbubble ultrasound contrast; “significant” v-aCS (15 microbubble emboli) correlated
with PFO on transesophageal echocardiography. A “major” v-aCS was 50 microbubbles
spontaneously or10 microbubbles spontaneously with80 after provocation. Venous blood
was taken for a thrombophilia screen.
RESULTS Myocardial infarction, more frequent in men, was associated with the usual cardiovascular risk
factors. More women suffered IS, which was associated only with migraine and hypertension.
Neither “significant” nor “major” v-aCS were associated with MI. “Major” v-aCS was found
in 24 (25%) IS cases compared with 12 (12%) control subjects (odds ratio 2.80, 95%
confidence interval 1.21 to 6.84; p  0.016). Thrombophilia was not significantly associated
with either MI or IS.
CONCLUSIONS Only “major” v-aCS were associated with stroke in young adults. Closure of smaller v-aCS
might not be justified. (J Am Coll Cardiol 2006;48:686–91) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.074College of Cardiology Foundation
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Tyocardial infarction (MI) and ischemic stroke (IS) are rare
n young adults and the etiology is often uncertain, with no
ause found in 30% to 40% of cases (1,2). Many of these
ryptogenic strokes in young adults might be caused by
aradoxical embolism, and a higher prevalence of patent
oramen ovale (PFO) has been reported in young adults
uffering IS (3,4). A meta-analysis of these case-control
tudies, which were often small and poorly designed, con-
rmed a significant association between PFO and IS in
dults below 55 years of age (5). Because paradoxical
mbolism might also occur through septal defects and
ulmonary arterio-venous malformations, we prefer the
erm venous-arterial circulation shunt (v-aCS) to right to
eft cardiac shunting.
From the *Academic Surgery Unit, South Manchester University Hospital,
anchester, United Kingdom; †Department of Medical Statistics, South Manchester
niversity Hospital, Manchester, United Kingdom; ‡Thrombosis Reference Centre,
outh Manchester University Hospital, Manchester, United Kingdom; Department
f Medicine, Manchester Royal Infirmary, Manchester, United Kingdom; and the
Department of Public Health Sciences, University of Alberta, Edmonton, Alberta,
anada. Support for this study was provided by the British Heart Foundation.i
Manuscript received September 8, 2005; revised manuscript received February 27,
006, accepted February 28, 2006.A PFO was identified on postmortem in 35% of all adults
ying under 30 years of age but in only 22% of older persons
6). The authors concluded that PFO might close in adult
ife, but we wondered whether PFO might be a cause of
remature deaths due to paradoxical embolism. We inves-
igated the role of paradoxical embolism through v-aCS in
oung adults surviving both MI and IS. If paradoxical
mbolism of venous thrombus causes either MI or IS, then
here might also be an association with the thrombophilias,
nown risk factors for venous thromboembolism (7). We
onducted a case-control study to investigate the fre-
uency of v-aCS and thrombophilia in young adults
urviving MI or IS—the first adequately powered study,
n the basis of sound epidemiological principles, to
xplore these associations and to include only adults 16 to
9 years of age in whom the prevalence of atherosclerosis
s low.
ETHODS
his case-control study was designed to answer the follow-
ng research questions:
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August 15, 2006:686–91 Paradoxical Embolism and Stroke. Is the frequency of v-aCS in young adults who have
suffered: 1) MI, or 2) IS higher than in similar young
adults without either condition?
. Is the frequency of thrombophilia in young adults who
have suffered: 1) MI, or 2) IS higher than in similar
young adults without either condition?
. Is the association between either v-aCS or thrombo-
philia and: 1) MI, or 2) IS independent of other
cardiovascular risk factors, and is any association still
significant after adjustment for such potential con-
founding?
ase recruitment. Young adults ages 16 to 39 years sur-
iving their first MI (International Classification of Diseases
ICD]-9: 410; ICD-10: I21, I22) or first IS (ICD-9: 433,
Abbreviations and Acronyms
APCr  activated protein C resistance
CI  confidence interval
GP  general practitioner
ICD  International Classification of Diseases
IS  ischemic stroke
MI  myocardial infarction
OR  odds ratio
PFO  patent foramen ovale
TCD  transcranial Doppler
TOE  transesophageal echocardiography
v-aCS  venous-to-arterial circulation shuntigure 1. Characteristic appearance of microbubbles on a middle cerebral art34, 436, 437.1; ICD-10: I63, I64, I67.2, I67.8, I67.9)
etween October 1, 1993, and December 31, 1998, were
dentified from all acute hospitals in the North West and
ersey Regions. Ethical approval was obtained from the
orth West Multi-Centre Research Ethics Committee.
ases of MI and stroke were confirmed on World Health
rganization criteria (8,9). The diagnosis in every case was
eviewed by diagnostic committee, including consultants in
ardiology and stroke medicine.
All eligible subjects were approached by asking the
elevant general practitioner (GP) to contact cases and
ontrol subjects by letter. All consenting subjects were
nvited to participate, and the first 101 cases and their
atched control subjects for each diagnosis were included.
ontrol recruitment. Six potential control subjects of the
ame gender and most closely matched to each case by age
ere drawn from the local community, using the same GP
ist as the case. The first to agree was included. All cases and
otential control subjects were recruited with strict inclusion
nd exclusion criteria.
nclusion criteria. For inclusion, young adults surviving
I and IS and matched population control subjects were:
16 to 39 years old at the time of the event
Currently residing within a 70-mile radius of Manchester
city center
A “district of residence” code within the study area at the
time of the eventery Doppler trace in a patient with a venous-to-arterial circulation shunt.
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Paradoxical Embolism and Stroke August 15, 2006:686–91xclusion criteria. Cases were excluded who had:
Surgery or injury requiring overnight hospital stay in the
10 weeks before the event.
Malignant disease diagnosed at any time.
ontrol subjects were excluded if there was a medical
istory of cardiovascular disease defined as MI, angina,
ransient cerebral ischemia, stroke, or any arterial throm-
osis.
ata collection. Full medical history, including cardiovas-
ular events and risk factors, were documented at a face-to-
ace interview with a structured questionnaire. Information
as referenced to the date of the case’s event for both cases
nd control subjects. The accuracy of this interview data was
alidated by examination of the GP notes in all subjects.
here was excellent concordance.
nvestigation for v-aCS. We developed a standardized
ranscranial Doppler (TCD) technique using intravenous
ltrasound contrast. The advantages over transesophageal
chocardiography (TOE) are that TCD: 1) is minimally
nvasive and comfortable for research patients; 2) detects
oth intracardiac and pulmonary arterio-venous shunts; and
) measures the functional significance of a v-aCS by
ounting the number of microbubble emboli entering the
iddle cerebral arteries. The TCD criteria (see the follow-
ng text) were sensitive and specific to the detection of PFO
hen compared with TOE (10).
Both middle cerebral arteries were insonated by a
euroguard (Medasonics, Fremont, California) TCD sys-
Table 1. Univariate Analysis of Cardiovascular
MI Cases
(n  101)
M
Age (yrs), mean (range) 35.3 (19–39)
Gender, male/female 69/32
Smoking 83
Hypertension 20
Cholesterol, mean (SD) 5.48 (1.08)
Diabetes mellitus 4
Body mass index, mean (SD) 28.7 (5.6)
Oral contraceptive pill 5
Migraine 34
Bold p values indicate statistically significant results.
CI  confidence interval; MI  myocardial infarction.
Table 2. Univariate Analysis of Cardiovascular
IS Cases
(n  101)
Age (yrs), mean (range) 33.2 (17–39)
Gender, male/female 43/58
Smoking 47
Hypertension 21
Cholesterol, mean (SD) 5.18 (0.90)
Diabetes mellitus 3
Body mass index, mean (SD) 25.8 (5.3)
Oral contraceptive pill 16
Migraine 63Bold p values indicate statistically significant results.
CI  confidence interval; IS  ischemic stroke.em with 2-MHz probes over the temporal windows set at
0- to 60-mm depth secured by a headband with the patient
itting upright. The Doppler signal was recorded onto
igital audio tape for blind analysis by a panel of 3 observers.
n emulsion of microbubbles as an ultrasound contrast was
repared by agitating a mixture of 8 ml saline, 1 ml air, and
.5 ml of the patient’s blood as an emulsificant between 2
0-ml syringes, 6 times through a 3-way tap. This emulsion
as then immediately injected via an 18-gauge cannula in
n antecubital vein. Our standardized protocol involved 2
njections under each of the following conditions: at rest,
fter vigorous coughing for 5 s, and after a standardized
alsalva maneuver (patients blew into a manometer to
aintain 40 mm Hg for 5 s).
In our validation study comparing our standardized TCD
echnique with TOE in 40 patients, 15 microbubble
mboli on TCD, defined as “significant” v-aCS, was 100%
pecific for PFO on TOE (Fig. 1) (10). A “major” shunt
50 microbubbles spontaneously or 10 microbubbles
pontaneously with 80 after provocation) identified pa-
ients with moderate or large shunts on TOE with 80%
ensitivity and 100% specificity. The TCD reproducibility
as also good with kappa results in excess of 0.8 for both
significant” and “major” shunts (11).
hrombophilia testing. Venous blood was taken for a
hrombophilia screen and lipid assays. Functional assays
ere used to test for activated protein C resistance (APCr);
upus anticoagulant; proteins C and S; antithrombin III;
brinogen; and Factors II, VII, VIII, and IX. Enzyme-
Factors in MI
ontrol Subjects
(n  101)
Odds Ratio
(95% CI) p Value
5.3 (19–39)
69/32
47 8.2 (3.24–20.75) <0.001
9 3.00 (1.09–8.25) 0.033
.37 (0.96) 1.09 (0.81–1.46) 0.56
0 0.12
6.0 (3.7) 1.13 (1.05–1.21) 0.001
6 0.75 (0.17–3.35) 0.71
38 1.24 (0.65–2.34) 0.52
Factors in IS Cases and Control Subjects
ontrol Subjects
(n  101)
Odds Ratio
(95% CI) p Value
3.2 (21–39)
43/58
41 1.32 (0.72–2.39) 0.37
8 2.86 (1.21–6.76) 0.017
.16 (0.92) 1.05 (0.77–1.45) 0.74
1 3.0 (0.31–28.8) 0.34
5.3 (4.0) 1.02 (0.96–1.08) 0.54
16 1.08 (0.49–2.37) 0.84
34 3.64 (1.86–7.09) <0.001Risk
I C
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August 15, 2006:686–91 Paradoxical Embolism and Strokeinked immunosorbent assay was used for anticardiolipin
ntibodies. Patients with APCr deficiency were investigated
or Factor V Leiden mutation, and those with raised Factor
I levels were investigated for prothrombin gene G20210A
utation. Patients on long-term warfarin therapy (5 MI
ases and 15 IS cases), which interferes with the functional
ssays, were tested only for Factor V Leiden and prothrom-
in gene G20210A mutations.
tatistical analysis and study power. Odds ratios (ORs)
etween the pairwise matched cases and control subjects for
-aCS and thrombophilia were computed with conditional
ogistic regression for MI and IS separately, adjusting for
onfounding factors where appropriate. For continuous
ariables, the ORs refer to the increased risk related to a 1-U
ncrease in the variable.
Assuming a frequency of v-aCS of 25% in control
ubjects and a frequency of thrombophilia of 5% in control
ubjects, 100 matched cases and control subjects would
etect an OR relating to v-aCS of 2.5 with a power of 80%
nd of 3.0 with a power of 95% and an OR relating to
hrombophilia of 3.0 with a power of 80% and of 4.0 with
power of 95%.
ESULTS
ists of patients with the relevant ICD codes were received
rom 22 hospitals identifying 741 potential cases (298 MI;
34 IS), of whom 227 met the diagnostic criteria for MI and
19 for IS. Of the 227 MI cases, 169 were contacted by
heir GP, 110 agreed to participate, and the first 101 were
ncluded. General practitioners contacted 173 of the 219 IS
able 3. Univariate and Multivariate Analysis of v-aCS in MI C
MI
Cases
MI Control
Subjects
Unadjusted
(95%
ignificant v-aCS 22 36 0.52 (0.
ajor v-aCS 11 16 0.67 (0.
Adjusted for hypertension, smoking, cholesterol, and diabetes.
CI  confidence interval; MI  myocardial infarction; v-aCS  venous-to-arter
Table 4. Univariate Analysis of Thrombophilia
MI Cases MI
Activated protein C resistance 5
Antithrombin III deficiency 0
Protein C deficiency 0
Protein S deficiency 0
Factor V Leiden 5
Prothrombin gene variant 4
Lupus anticoagulant 17
IgG anticardiolipin antibodies 3
IgM anticardiolipin antibodies 8
Fibrinogen assay, mean (SD) 3.39 (0.63)
Fibrinogen screen, mean (SD) 4.51 (1.06)
Factor II, mean (SD) 104.7 (12.0)
Factor VII, mean (SD) 113.0 (21.1)
Factor VIII, mean (SD) 143.8 (47.5)
Factor IX, mean (SD) 137.9 (34.7)Bold p values indicate statistically significant results.
CI  confidence interval; Ig  immunoglobulin; MI  myocaases, 110 agreed to participate, and the first 101 were
ncluded.
Individually matched control subjects were recruited for
5 MI and 90 IS cases. Six control subjects for MI and 11
or IS were successfully matched by gender and age but not
y GP list. Matching within 1 year of age was achieved in
8% of MI pairs and 97% of IS pairs.
ase and control characteristics. Nearly 70% of MI cases
ere men (Table 1) compared with only 43% of IS patients
Table 2). Risk factors for atherosclerosis, such as smoking
nd raised body mass index were more frequent in MI cases
han in either control subjects or IS cases. Hypertension was
ignificantly more frequent in both MI and IS cases than
heir control subjects. Migraine was associated with IS but
ot MI.
I cases and control subjects. FREQUENCY OF v-aCS. A
significant” v-aCS in was found in 22 (23%) MI patients
ompared with 36 (38%) matched control subjects with an
R of 0.52 (95% confidence interval [CI] 0.28 to 0.96,
 0.038) (Table 3). After adjustment for confounding
actors, this OR was 0.61 (95% CI 0.28 to 1.36, p  0.23).
Major” v-aCS were found in 11 (12%) of MI cases and 16
17%) control subjects (unadjusted OR 0.67 [95% CI 0.30
o 1.48], p 0.32; adjusted OR 1.19 [95% CI 0.45 to 3.13],
 0.73).
HROMBOPHILIA RESULTS. There were no differences be-
ween MI cases and control subjects for APCr, anti-
hrombin III, protein C, protein S, lupus anticoagulant,
nticardiolipin antibodies, Factor V Leiden gene, and
rothrombin variant gene (Table 4). Fibrinogen and Factors
nd Control Subjects
s Ratio
p Value
Adjusted* Odds Ratio
(95% CI) p Value
96) 0.038 0.61 (0.28–1.36) 0.23
48) 0.32 1.19 (0.45–3.13) 0.73
ulation shunt.
ults in MI Cases and Control Subjects
trol Subjects Odds Ratio (95% CI) p Value
8 0.62 (0.20–1.91) 0.41
1
1
1
8 0.62 (0.20–1.91) 0.41
3 1.33 (0.30–5.96) 0.71
11 1.60 (0.73–3.52) 0.24
9 0.33 (0.09–1.23) 0.1
5 1.60 (0.52–4.89) 0.41
02 (0.54) 2.86 (1.60–5.24) <0.001
97 (0.89) 1.8 (1.26–2.56) 0.001
.7 (12.3) 1.04 (1.01–1.07) 0.002
.5 (21.0) 1.02 (1.00–1.03) 0.019
.7 (31.2) 1.02 (1.01–1.03) <0.001
.5 (30.5) 1.02 (1.00–1.03) 0.004ases a
Odd
CI)
28–0.
30–1.Res
Con
3.
3.
98
105
111
122rdial infarction.
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Paradoxical Embolism and Stroke August 15, 2006:686–91I, VII, VIII, and IX were significantly elevated in MI cases
ompared with their control subjects.
troke cases and control subjects. FREQUENCY OF
-aCS. A “significant” v-aCS was found in 43 (45%) IS
atients compared with 38 (40%) control subjects, giving a
onsignificant OR of 1.22 (95% CI 0.70 to 2.11; p  0.48)
Table 5). This OR was increased only marginally by
djustment for confounding factors to 1.34 (95% CI 0.74 to
.42; p  0.33). However, “major” v-aCS were found in 24
25%) IS cases compared with only 12 (12%) control
ubjects giving an OR of 2.20 (95% CI 1.04 to 4.64; p 
.039). After adjustment for confounding factors, this OR
emained significant at 2.80 (95% CI 1.21 to 6.48; p 
.016).
HROMBOPHILIA RESULTS. Levels of Factors VII and VIII
ere significantly higher in IS cases than control subjects,
ut there were no differences in the frequency of APCr,
ntithrombin III, protein C, protein S, lupus anticoagulant,
nticardiolipin antibodies, Factor V Leiden gene, and pro-
hrombin variant gene (Table 6).
ISCUSSION
his is the first adequately powered case-control study of
ppropriate epidemiological standards to explore definitively
he association between v-aCS and both MI and IS in
oung adults. No relationship was found between v-aCS
nd MI, consistent with a previous smaller study on fre-
uency of PFO in patients with MI and normal coronary
rteries (12). In IS, only “major” v-aCS was significantly
able 5. Univariate and Multivariate Analysis of v-aCS in IS Ca
IS
Cases
IS Control
Subjects
Unadjusted
(95%
ignificant v-aCS 43 38 1.22 (0.7
ajor v-aCS 24 12 2.20 (1.0
Adjusted for hypertension, smoking, cholesterol, and diabetes. Bold p values indica
CI  confidence interval; IS  ischemic stroke; v-aCS  venus-to-arterial circu
Table 6. Univariate Analysis of Thrombophilia
IS Cases IS
Activated protein C resistance 3
Antithrombin III deficiency 3
Protein C deficiency 1
Protein S deficiency 1
Factor V Leiden 4
Prothrombin gene variant 2
Lupus anticoagulant 9
IgG anticardiolipin antibodies 9
IgM anticardiolipin antibodies 1
Fibrinogen assay, mean (SD) 3.06 (0.63)
Fibrinogen screen, mean (SD) 4.02 (1.10)
Factor II, mean (SD) 98.3 (11.1)
Factor VII, mean (SD) 105.8 (22.2)
Factor VIII, mean (SD) 128.0 (42.5)
Factor IX, mean (SD) 129.6 (35.2)Bold p values indicate statistically significant results.
CI  confidence interval; Ig  immunoglobulin; IS  ischemiore common than in control subjects. Previous studies
ave also suggested that only large shunts were associated
ith stroke in the young (13). Current clinical trials that
andomize all IS patients with a PFO to medical therapy or
ransvenous closure of the PFO might prove insensitive to
he therapeutic effect of these treatments, because it will be
iluted by smaller PFOs where therapeutic benefit is un-
ikely.
Contrast TCD proved to be a simple and effective way to
etect v-aCS. If used as the initial investigation for v-aCS in
oung patients suffering IS, only those with “significant” if
ot a “major” v-aCS would require TOE to distinguish
FO from other causes of v-aCS and assess anatomical
uitability for closure. Otherwise only patients with an
nadequate temporal window for TCD would require TOE.
The expected strong association between MI and risk
actors for atherosclerosis was not found in IS cases (14).
he association between migraine and IS was again con-
rmed (15). Data on smoking, migraine, and the patient’s
eight was based on their memory of circumstances at the
ime of the case’s event up to 7 years previously. There is no
eason to believe that errors in recollection would differ
etween cases and control subjects.
Factor V Leiden, antithrombin III, protein C or protein
deficiency, and prothrombin gene variant—all known to
e associated with venous thromboembolism—were not
ssociated significantly with either MI or IS. Elevated
brinogen levels, well-recognized in atherosclerosis, were
ound in MI but not in IS cases (16). The raised fibrinogen
evels and atherosclerotic risk factors found in MI but not IS
d Control Subjects
Ratio
p Value
Adjusted* Odds Ratio
(95% CI) p Value
1) 0.48 1.34 (0.74–2.42) 0.33
4) 0.039 2.80 (1.21–6.48) 0.016
istically significant results.
shunt.
ults in IS Cases and Control Subjects
trol Subjects Odds Ratio (95% CI) p Value
8 0.43 (0.11–1.67) 0.22
0
0
1
8 0.50 (0.15–1.66) 0.26
0
7 1.60 (0.52–4.89) 0.41
4 4.00 (0.85–18.8) 0.08
5 0.20 (0.02–1.71) 0.14
00 (0.59) 1.20 (0.70–2.07) 0.51
91 (1.02) 1.12 (0.82–1.52) 0.48
.3 (9.4) 1.02 (0.99–1.05) 0.20
.0 (22.1) 1.02 (1.00–1.04) 0.013
.6 (27.4) 1.01 (1.00–1.03) 0.019
.9 (34.3) 1.01 (1.00–1.02) 0.08ses an
Odds
CI)
0–2.1
4–4.6Res
Con
3.
3.
96
96
113
119c stroke.
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August 15, 2006:686–91 Paradoxical Embolism and Strokeases suggest a different etiology for MI and IS in young
dults.
onclusions. Risk factors for atherosclerosis were associ-
ted with MI but not with IS. There was no association
etween v-aCS and MI, but the increased frequency of
major” v-aCS in IS argues for appropriate TCD or TOE
nvestigation of young IS patients, with a view to anticoag-
lation or transvenous closure in those with a “major” v-aCS
ue to PFO. There is no evidence to justify closure of
nsignificant or moderate v-aCS. Clinical trials on antico-
gulation or PFO closure should focus on patients with
major” v-aCS.
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